iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI – Get Free Report) saw a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 7,578 shares, an increase of 91.5% from the July 30th total of 3,958 shares. Based on an average trading volume of 3,628 shares, the days-to-cover ratio is presently 2.1 days. Currently, 1.2% of the shares of the stock are short sold.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in iShares LifePath Target Date 2065 ETF stock. Orion Porfolio Solutions LLC acquired a new stake in iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,554 shares of the company’s stock, valued at approximately $465,000. Orion Porfolio Solutions LLC owned about 2.85% of iShares LifePath Target Date 2065 ETF at the end of the most recent quarter.
iShares LifePath Target Date 2065 ETF Stock Down 0.3%
NYSEARCA:ITDI opened at $43.10 on Tuesday. The firm’s fifty day simple moving average is $42.38 and its 200-day simple moving average is $40.68. The stock has a market cap of $27.58 million, a PE ratio of 20.19 and a beta of 0.89. iShares LifePath Target Date 2065 ETF has a fifty-two week low of $35.36 and a fifty-two week high of $43.70.
About iShares LifePath Target Date 2065 ETF
The iShares LifePath Target Date 2065 ETF (ITDI) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2065 ITDI was launched on Oct 17, 2023 and is issued by BlackRock.
See Also
- Five stocks we like better than iShares LifePath Target Date 2065 ETF
- Space Race Meets Ground Reality for Tower REITs
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
Receive News & Ratings for iShares LifePath Target Date 2065 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2065 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
